Kinney Horn

CIK: 0001831215

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMNM

Immunome Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

IMNM
Immunome Inc.
Aug 4, 2026
Exercise(M)
Direct
50.4K shares at avg. $12.92$651K
IMNM
Immunome Inc.
Aug 4, 2026
Exercise(M)
Direct
40.3K shares at avg. $10.60$427K
IMNM
Immunome Inc.
Aug 4, 2026
Sale(S)
Direct
90.6K shares at avg. $25.09$2.3M
IMNM
Immunome Inc.
Jul 23, 2026
Award(A)
Direct
31.3K shares-
IMNM
Immunome Inc.
Jul 7, 2026
Exercise(M)
Direct
1.1K shares at avg. $12.92$14K
IMNM
Immunome Inc.
Jul 7, 2026
Sale(S)
Direct
1.1K shares at avg. $25.00$27K
IMNM
Immunome Inc.
Jul 29, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
161K shares-

		Type	Shares	Price		Ownership
Aug 4, 2026	IMNM Immunome Inc.	Exercise(M)	50,366	$12.92	$650,729	Direct
Aug 4, 2026	IMNM Immunome Inc.	Exercise(M)	40,250	$10.60	$426,650	Direct
Aug 4, 2026	IMNM Immunome Inc.	Sale(S)	90,616	$25.09	$2,273,555	Direct
Jul 23, 2026	IMNM Immunome Inc.	Award(A)	31,250	-	$0	Direct
Jul 7, 2026	IMNM Immunome Inc.	Exercise(M)	1,092	$12.92	$14,109	Direct
Jul 7, 2026	IMNM Immunome Inc.	Sale(S)	1,092	$25.00	$27,300	Direct
Jul 29, 2025	IMNM Immunome Inc.	Award(A) Employee Stock Option (right to buy)	161,000	-	-	Direct

1-7 of 7 transactions

About Horn Kinney

Horn Kinney (SEC CIK 0001831215) files insider reports with the SEC as CHIEF BUSINESS OFFICER of Immunome Inc. (IMNM).

Signal8 holds 4 ownership filings by Horn Kinney, all Form 4s, filed between Jul 31, 2025 and Aug 6, 2026. Those filings report 7 transactions, from Jul 29, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Horn Kinney's filings is in BOTHELL, WA.

Recent filings by Horn Kinney

Aug 4, 2026: Option exercises of IMNM shares (2 lines, Form 4, code M).
Aug 4, 2026: Open-market sale of IMNM shares (Form 4, code S).
Jul 23, 2026: Grant or award of IMNM shares (Form 4, code A).
Jul 7, 2026: Option exercise of IMNM shares (Form 4, code M).
Jul 7, 2026: Open-market sale of IMNM shares (Form 4, code S).

Other insiders filing for Immunome Inc. (IMNM)

Higgins Jack, Chief Scientific Officer
Barchas Isaac, Director
Tsai Philip, Chief Technical Officer
Stoneman Sandra G., CHIEF LEGAL OFFICER & GC
Rosett Max, Chief Financial Officer
Lechleider Robert, Chief Medical Officer

How to read Form 4 transaction codes